Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
613.78
-4.65 (-0.75%)
At close: Sep 4, 2026, 4:00 PM EDT
611.50
-2.28 (-0.37%)
After-hours: Sep 4, 2026, 7:58 PM EDT
Thermo Fisher Revenue
Thermo Fisher had revenue of $11.99B in the quarter ending June 27, 2026, with 10.49% growth. This brings the company's revenue in the last twelve months to $46.34B, up 7.23% year-over-year. In the year 2025, Thermo Fisher had annual revenue of $44.56B with 3.91% growth.
Revenue (ttm)
$46.34B
Revenue Growth
+7.23%
P/S Ratio
4.90
Revenue / Employee
$370,688
Employees
125,000
Market Cap
226.94B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.56B | 1.68B | 3.91% |
| Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
| Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
| Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
| Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
| Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
| Dec 31, 2019 | 25.54B | 1.18B | 4.86% |
| Dec 31, 2018 | 24.36B | 3.44B | 16.45% |
| Dec 31, 2017 | 20.92B | 2.64B | 14.47% |
| Dec 31, 2016 | 18.27B | 1.31B | 7.72% |
| Dec 31, 2015 | 16.97B | 75.40M | 0.45% |
| Dec 31, 2014 | 16.89B | 3.80B | 29.02% |
| Dec 31, 2013 | 13.09B | 580.40M | 4.64% |
| Dec 31, 2012 | 12.51B | 951.10M | 8.23% |
| Dec 31, 2011 | 11.56B | 1.17B | 11.22% |
| Dec 31, 2010 | 10.39B | 481.50M | 4.86% |
| Dec 31, 2009 | 9.91B | -586.40M | -5.59% |
| Dec 31, 2008 | 10.50B | 751.60M | 7.71% |
| Dec 31, 2007 | 9.75B | 5.95B | 157.05% |
| Dec 31, 2006 | 3.79B | 1.16B | 44.00% |
| Dec 31, 2005 | 2.63B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Danaher | 25.11B |
| IQVIA Holdings | 16.98B |
| Labcorp Holdings | 14.35B |
| Quest Diagnostics | 11.56B |
| Agilent Technologies | 7.37B |
| Waters | 4.64B |
| IDEXX Laboratories | 4.55B |
| Illumina | 4.49B |
TMO News
- 4 days ago - Thermo Fisher initiated with an Outperform at CLSA - TheFly
- 5 days ago - Why Moderna's Cancer Vaccine Matters to Investors - ETF Trends
- 5 days ago - Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader to Help Simplify Protein, Cell and Microbial Analysis - Business Wire
- 6 days ago - Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026 - Business Wire
- 11 days ago - Thermo Fisher introduces Thermo Scientific EMPAD G2 detector - TheFly
- 11 days ago - Thermo Fisher Scientific Introduces the Thermo Scientific™ EMPAD™ G2 Electron Detector to Advance Materials Research - Business Wire
- 13 days ago - Thermo Fisher Scientific Launches First Orbitrap Mass Spectrometers for Isotope Ratio Analysis, Enabling More Labs to Decode the Story Behind a Sample - Business Wire
- 21 days ago - Thermo Fisher complete sale of its microbiology business to Astorg for $1.075B - TheFly